CD8α Structural Domains Enhance GUCY2C CAR-T Cell EfficacyTrevor R. Baybutt(Thomas Jefferson University), Adam E. Snook(Thomas Jefferson University)Cancer Biology & TherapySeptember 24, 202410.1080/15384047.2024.2398801Cited by 9SaveCiteExport RISWatch citationsRelated PapersCD5 deletion enhances the antitumor activity of adoptive T cell therapies|Science Immunology|2024|45Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy|npj Vaccines|2022|16Clinical Development of <i>Senza5TM CART5:</i> a Novel Dual Population CD5 CRISPR-Cas9 Knocked out Anti-CD5 Chimeric Antigen Receptor T Cell Product for Relapsed and Refractory CD5+ Nodal T-Cell Lymphomas|Blood|2022|8